Nanoconjugated long non-coding RNA MEG3 as a new therapeutic approach for Hepatocellular carcinoma
Background: Hepatocellular carcinoma (HCC) is an aggressive human cancer with a poor prognosis. Long non-coding RNAs (lncRNA) have multiple functions: epigenomic regulation, gene transcription, protein-coding gene translation, and genome defense. The involvement of lncRNAs in therapy offers a vast s...
Main Authors: | Mohamed Elzallat, Marwa Hassan, Nabila Elkramani, Tarek Aboushousha, Ahmed AbdelLatif, Noha Helal, Hoda Abu-Taleb, Eman El-Ahwany |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-04-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844023024957 |
Similar Items
-
The Impact of Single Nucleotide Polymorphism in the Long Non-coding MEG3 Gene on MicroRNA-182 and MicroRNA-29 Expression Levels in the Development of Breast Cancer in Egyptian Women
by: Olfat Shaker, et al.
Published: (2021-08-01) -
The lncRNA MEG3 downregulation leads to osteoarthritis progression via miR-16/SMAD7 axis
by: Jin Xu, et al.
Published: (2017-12-01) -
Prediction of prognosis, immune infiltration, and personalized treatment of hepatocellular carcinoma by analysis of cuproptosis-related long noncoding RNAs and verification in vitro
by: Shanbao Li, et al.
Published: (2023-09-01) -
Clinical Value of lncRNA MEG3 in High-Grade Serous Ovarian Cancer
by: Marianna Buttarelli, et al.
Published: (2020-04-01) -
Prognostic and immunological role of sulfatide-related lncRNAs in hepatocellular carcinoma
by: Xing Feng Huang, et al.
Published: (2023-02-01)